Welcome to our dedicated page for Sotera Health Co news (Ticker: SHC), a resource for investors and traders seeking the latest updates and insights on Sotera Health Co stock.
Sotera Health Company (NASDAQ: SHC) is described as a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Through its Sterigenics, Nordion and Nelson Labs businesses, the company focuses on sterilization, analytical testing and related services that support the safety of medical, pharmaceutical and food products.
The SHC news feed on Stock Titan highlights company announcements that matter to investors and observers of the healthcare services and testing laboratories space. These include quarterly and year-to-date financial results, updates on revenue trends and segment performance for Sterigenics, Nordion and Nelson Labs, as well as information on leverage, credit facilities and other balance sheet items described in press releases and Form 8-K filings.
Users can also follow news about secondary offerings of common stock by selling stockholders, as disclosed in company press releases and related 8-K filings. These items explain when affiliates of investment firms have sold blocks of SHC shares and clarify that Sotera Health did not receive proceeds from those transactions.
Regulatory and legal developments are another important category of news for Sotera Health. Public disclosures describe litigation and settlements related to ethylene oxide emissions at certain Sterigenics facilities, along with broader risk discussions around EO, Co-60 supply, regulatory changes and international operations. Conference participation, earnings release dates and management presentations at healthcare investor events are also covered in the company’s news flow.
By reviewing this news stream, readers can see how Sotera Health communicates its financial performance, capital markets activity, legal developments and strategic positioning in sterilization and lab testing services over time.
Sotera Health Company (Nasdaq: SHC) has appointed Michael F. Biehl as the new Interim Chief Financial Officer effective July 20, 2022, following Scott Leffler's departure. Biehl brings nearly 20 years of experience in public company CFO roles. Sotera Health plans to release its second-quarter financial results for the period ending June 30, 2022, on August 4, 2022, prior to the market open, followed by a conference call at 9:00 a.m. ET to discuss operational highlights and financial metrics.
Sotera Health Company (NASDAQ: SHC) announced the departure of CFO Scott Leffler after over five years, effective August 12, 2022, as he relocates to Florida for a new role. The search for a permanent replacement is underway. Leffler's exit is not linked to any operational issues within the company. CEO Michael B. Petras, Jr. expressed gratitude for Leffler's contributions and confidence in the company's future growth, emphasizing its commitment to the mission of safeguarding global health.
Sterigenics has officially launched operations at its newly expanded electron beam (E-beam) facility in Columbia City, Indiana. This expansion aims to enhance sterilization services for medical devices and pharmaceutical products, meeting growing customer demands. The installation of a new E-beam accelerator increases sterilization capacity, ensuring safety for healthcare products. Notably, Sterigenics emphasizes improved productivity, reliability, and safety as part of this facility's upgrade, aligning with its mission of Safeguarding Global Health.
Sotera Health Company (Nasdaq: SHC) reported Q1 2022 net revenues of $237 million, a 12% increase from Q1 2021. Net income rose to $31 million or $0.11 per share, compared to $11 million or $0.04 per share last year. Adjusted EBITDA reached $115 million, up by 10%. The company reaffirmed its 2022 financial outlook, expecting net revenues between $1.0 billion and $1.03 billion. Despite challenges like the Omicron surge and geopolitical issues, Sotera Health emphasized strong execution and strategic capacity building.
Sotera Health Company (Nasdaq: SHC) plans to release its financial results for Q1 2022 on May 5, 2022, before market open. A conference call to discuss the results will take place at 9:00 a.m. Eastern Time. Participants can join by dialing 1-866-777-2509 from the U.S. or 1-412-317-5413 internationally. A live webcast of the call will be available on the company’s Investor Relations website, with a replay accessible later on the same day.
Sotera Health Company (Nasdaq: SHC) has launched the Sotera Health Academy, a new educational platform offering over 100 hours of curated content aimed at supporting MedTech and Pharmaceutical customers. The Academy features more than 150 resources, including webinars and eBooks, created by industry experts from Nelson Labs, Sterigenics, and Nordion. This initiative follows Sotera's acquisition of Regulatory Compliance Associates, enhancing the platform's offerings. The Academy aims to help manufacturers navigate regulatory risks and accelerate product market entry.
Sotera Health Company (Nasdaq: SHC) reported a strong financial performance for Q4 2021, with net revenues increasing by 11.3% to $241 million and a net income of $36 million, recovering from a loss of $44 million in the previous year. For the full year, revenues rose 13.9% to $931 million, with net income of $117 million compared to a loss of $39 million in 2020. The company expects 2022 revenue growth of 7% to 11% and plans significant investments in capacity expansions. Total debt stood at $1.8 billion with a net leverage ratio of 3.5x as of December 31, 2021.
Nelson Labs has launched the Nelson Labs Mark, a verification program aimed at enhancing transparency in product testing, particularly for face masks and respirators. This initiative addresses the rise of fraudulent products during the ongoing COVID-19 pandemic, providing consumers and institutions with reliable data on product performance. The program includes two-factor authentication for product verification and will expand to include other products as needed. This effort is part of Nelson Labs' mission to safeguard global health.
Sotera Health Company (Nasdaq: SHC) will announce its financial results for Q4 and full year ended December 31, 2021, on March 1, 2022, before market open. The company is a leading provider of sterilization solutions and lab testing services for healthcare. Following the announcement, a conference call will take place at 9:00 a.m. ET to discuss operating highlights and results. Interested participants can access the call via a dedicated phone line or through a live webcast on the company’s Investor Relations website.
Sotera Health Company (NASDAQ: SHC) has provided an update on its growth and achievements during the 40th Annual J.P. Morgan Healthcare Conference. The company expects its full-year 2021 revenues to reach between $920 million and $930 million, reflecting a growth of approximately 14% from the previous year. CEO Michael B. Petras, Jr. emphasized the company's strong execution throughout 2021 and shared insights on its long-term growth strategy and ESG initiatives. Full financial results for Q4 and year-end 2021 will be reported on March 1, 2022.